Cardiopulmonary bypass (CPB) is an essential component of modern cardiac surgery, allowing surgeons to temporarily replace heart and lung function during complex procedures. One important technical aspect of CPB management involves minimizing hemodilution, which occurs when crystalloid solutions used to prime the bypass circuit dilute the patient’s blood. Excessive hemodilution can reduce hematocrit levels and increase the likelihood of blood transfusions. As a result, clinicians continuously seek methods to reduce prime volume and preserve the patient’s native blood components.

The study “Initiating Cardiopulmonary Bypass Using a Dry Venous Line: Implications and Analysis” examines an alternative strategy to reduce hemodilution: initiating CPB using a dry venous line in combination with vacuum-assisted venous drainage (VAVD). This method removes crystalloid fluid from the venous tubing before initiating bypass so that the patient does not receive that additional fluid volume. While this technique may reduce hemodilution, it may also introduce risks, particularly the formation of gaseous microemboli (GME) within the extracorporeal circuit.

Gaseous microemboli are small air bubbles that can enter the bloodstream during CPB. These bubbles can travel through the circulation and potentially contribute to neurological complications or other adverse outcomes. Previous studies have demonstrated that increased microemboli exposure during bypass may correlate with postoperative cognitive dysfunction or neurological deficits. Therefore, balancing blood conservation strategies with patient safety remains an important clinical challenge. 

To investigate the potential risks associated with dry venous line initiation, the researchers designed a controlled laboratory experiment using a simulated adult CPB circuit. The experimental setup included a modern extracorporeal circuit with a LivaNova Inspire 8F oxygenator that contained an integrated arterial filter. The circuit was connected to a heart-lung machine and various sensors to measure gaseous microemboli throughout the system.